1. Home
  2. ATXG vs CMND Comparison

ATXG vs CMND Comparison

Compare ATXG & CMND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ATXG

Addentax Group Corp.

N/A

Current Price

$0.52

Market Cap

5.5M

ML Signal

N/A

Logo Clearmind Medicine Inc.

CMND

Clearmind Medicine Inc.

HOLD

Current Price

$0.07

Market Cap

5.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATXG
CMND
Founded
2014
2017
Country
China
Canada
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.5M
5.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ATXG
CMND
Price
$0.52
$0.07
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
55.3K
22.7M
Earning Date
11-14-2025
01-21-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,141,952.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.36
$0.07
52 Week High
$1.86
$2.18

Technical Indicators

Market Signals
Indicator
ATXG
CMND
Relative Strength Index (RSI) 49.45 15.25
Support Level $0.46 $0.07
Resistance Level $0.55 $0.13
Average True Range (ATR) 0.04 0.02
MACD 0.02 0.02
Stochastic Oscillator 68.23 6.01

Price Performance

Historical Comparison
ATXG
CMND

About ATXG Addentax Group Corp.

Addentax Group Corp is an investment holding company. The company through its operating subsidiaries functions in the following segments; Garment manufacturing; Logistics services; Property management and subleasing. It generates maximum revenue from the Logistics services segment which provides logistics services including storage, transportation, warehousing, handling, packaging, and order processing. It also provides customs declaration and tax clearance services to its customers who export goods overseas. Geographically, the company derives all of its revenue from China.

About CMND Clearmind Medicine Inc.

Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.

Share on Social Networks: